Pharmacy Benefits Management

January 10, 2022

Quviviq Receives Approval to Treat Insomnia

January 10, 2022 – Quviviq (daridorexant – Idorsia) has received FDA approval to treat adults who have insomnia characterized by difficulties with sleep onset and/or sleep
January 4, 2022

First Generic for Cuvposa Launches

January 4, 2022 – Par Pharmaceutical has launched the first generic version of Merz Pharmaceuticals’ Cuvposa® (glycopyrrolate) oral solution. Both Cuvposa and its generic are indicated
December 28, 2021

Adbry Approved for Atopic Dermatitis

December 28, 2022 – Leo Pharma's AdbryTM (tralokinumab-ldrm) has received FDA approval to treat moderate to severe atopic dermatitis in adults whose disease is not adequately